Our Products

Our products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. More

Research & Growth

We recognize the immense value of clinical research and are committed to investing in it to expand the body of knowledge in our therapeutic areas and advance potential future health innovations for patients. More

AMAG Corporate Principles

Our company values provide an important framework for who we are and how we operate. AMAG is also committed to a set of corporate principles that guide how we pursue our business goals and deliver on our promise to patients and their families. More

News

AMAG Pharmaceuticals Announces Preliminary 2017 Financial Results and Provides...

AMAG Pharmaceuticals Announces Preliminary 2017 Financial Results and Provides 2018 Guidance

WALTHAM, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today provided a business update, including preliminary unaudited More

AMAG Pharmaceuticals Awards $300,000 in Grants to Further Research in Preterm...

AMAG Pharmaceuticals Awards $300,000 in Grants to Further Research in Preterm Birth and Neonatal Health

WALTHAM, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) --  As part of the company’s ongoing support of maternal and neonatal health, AMAG Pharmaceuticals, Inc. More

Working at AMAG

"I get to wear a lot of different hats in an industry that provides very fast-paced and interesting work along with the opportunity to solve the puzzle of treatments for difficult diseases."

David Knauss
Senior Manager, Regulatory Affairs & Medical Writing